EMEA-001172-PIP01-11 - paediatric investigation plan

brinzolamide

brimonidine tartrate

Key facts

• Active Substance:
  • brinzolamide
  • brimonidine tartrate
• Therapeutic area:
  Ophthalmology
• Decision number:
  P/259/2011
• PIP number:
  EMEA-001172-PIP01-11
• Pharmaceutical form(s):
  • Eye drops, solution
  • Suspension
• Condition(s) / indication(s):
  Treatment of glaucoma
• Route(s) of administration:
  Ocular use
• Decision type:
  W: decision granting a waiver in all age groups for all conditions or indications
• Decision date:
  26/10/2011

Decision

P/259/2011: EMA decision of 26 October 2011 on the granting of a product specific waiver for brinzolamide / brimonidine (tartrate) (EMEA-001172-PIP01-11)

AdoptedReference Number: EMA/764077/2011